
Congratulations to @christinemphmd and @ev_lando for running in the 50th @nycmarathon! We’re so proud of our team members! What an amazing feat 🏅 (cc: @WCMLymphoma @WCMLungCancer)

The Weill Cornell Medicine Lymphoma Program seeks to enable people with lymphoma to have the best possible clinical outcome. fb.com/weillcornelllymphoma

Congratulations to @christinemphmd and @ev_lando for running in the 50th @nycmarathon! We’re so proud of our team members! What an amazing feat 🏅 (cc: @WCMLymphoma @WCMLungCancer)

Beyond the scale: Could GLP-1 medications play a role in #cancer prevention and care? Dr. Louis Aronne joined me on #CancerCast to explain how these drugs work in the body and what this might mean for patients and cancer risk bit.ly/4xH0yOg Please enjoy the podcast !

After finishing her fellowship @WCMHemOncFellow, Dr. Evelyn Orlando (@ev_lando) joined us as a faculty member this month and will be caring for patients with #lymphoma. An official warm welcome to the team! bit.ly/4xrCSOt

Join us in welcoming the new head of our @WeillCornell #Lymphoma program, Dr. Paul Hamlin! Dr. Hamlin brings decades of experience and we’re excited to have him leading our team. Learn more about him and make an appointment here: bit.ly/4gI2Xld

Dr. John Allan spoke with @OncLive about how different treatment options compare to one another for chronic lymphocytic leukemia (CLL): bit.ly/4bKl6NB

WATCH: Dr. Erin Mulvey discusses treatment data for first-line Bruton’s tyrosine kinase (BTK) inhibitors for chronic lymphocytic leukemia (CLL) bit.ly/4xUk8Hp

Listen to Dr. John Allan on the @OncLive On Air podcast where he discussed treatment regimens for chronic lymphocytic leukemia (CLL) and how to improve outcomes for high-risk patients: bit.ly/3TSLVJp

More people are diagnosed with and surviving #cancer than ever before. On @WeillCornell #CancerCast I spoke with Dr. Emily Tonorezos about #CancerSurvivorship and how pts can live well beyond cancer bit.ly/4fqes1J #NationalCancerSurvivorMonth #NCSD2026 @BreastCancerNow

A truly multi-institutional collaboration featuring @WCMLymphoma, @MayoClinic, @uiowa, @washumedicine, @umiamimedicine, @UTMDAnderson, @UNC, @UR_Med, @EmoryMedicine, @nyulangone, @AalborgUH among others!

#Research published in @BloodcancerJnl from @WeillCornell @WCMCPathology found that #HodgkinLymphoma develops as a result of an arrested stage of B cell development: bit.ly/42LHSzR

Dr. @HBesien’s #research focuses on growing the most effective Epstein-Barr virus-specific T cells (EBV-CTLs) with the long-term goal of expanding this promising therapy to more patients with EBV-related #Lymphomas.

Congratulations to @WCMHemOncFellow's @John_Will_I_Am @kimberlyloomd @MollyGilligan1 & @HBesien on receiving their @ASCO @ConquerCancerFd Young Investigator Awards! Amazing work! Well-deserved! @nyphospital @WeillCornell @WCMGIcancer @WCMCutaneousOnc @WCMLeukemia @WCMLymphoma
We're thrilled to officially announce the 2026 class of Conquer Cancer Grants and Awards recipients! 🔬 These grants empower the next generation of physician-scientists to turn innovative ideas into clinical breakthroughs. Congratulations to the new class—see you in Chicago for #ASCO26! Full list of recipients here: bit.ly/4x0qpBF #ResearchConquersCancer #ConquerCancer @ASCO

A new @WeillCornell #CancerCast episode with @DrPinkalDesai just dropped. Hear about how we can now find common aging-related mutations(#CHIP #Blood) in the blood that are linked to cancer, inflammation, cardiovascular disease and other health risks bit.ly/4nIJbcl

Happy #ClinicalTrialsDay! Today and every day, our staff and faculty @WeillCornell @nyphospital celebrate the impact clinical research has made on the community and how we are collectively changing medicine through the power of #research. #CTD2026 @ACRPDC

Join members of our #BloodCancer team for a #CME symposium hosted by @nyphospital and @WCM_MeyerCancer on improving the diagnosis, treatment and referral pathways for patients with blood cancers in Brooklyn. Learn more and register: bit.ly/4tKkvlf

WATCH: Dr. Erin Mulvey discusses the changing treatment landscape for Richter Transformation, a rare condition where chronic lymphocytic leukemia (#CLL) or small lymphocytic #Lymphoma (SLL) turns into a more aggressive form of lymphoma bit.ly/4cKkW9P